Mode
Text Size
Log in / Sign up

Meridian Sinew Tuina significantly reduces upper limb circumference and pain in breast cancer-related lymphedemaMeridian Sinew Tuina May Help Manage Breast Cancer Lymphedema

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider Meridian Sinew Tuina as an optional adjunctive therapy to reduce limb circumference and pain in BCRL.

This meta-analysis synthesized evidence regarding the efficacy of Meridian Sinew Tuina (MST), a deep tissue mobilization technique, for patients with breast cancer-related lymphedema (BCRL). The analysis included 1,114 patients for clinical response outcomes and 924 patients for anthropometric and secondary outcomes.

Key findings include a significant reduction in upper limb circumference (SMD = 1.59; 95% CI: 1.44 to 1.74; p < 0.0001). Clinical Response Efficacy Rate favored MST (RR = 1.69; 95% CI: 1.54 to 1.87; p < 0.0001). Furthermore, patients reported favorable 3-month improvements in DASH functional scores (SMD = -1.81; 95% CI: -2.11 to -1.51), pain intensity (SMD = -2.44; 95% CI: -2.93 to -1.95), and quality of life (SMD = 1.04; 95% CI: 0.79 to 1.29).

The authors note limitations including unblinded performance bias and variations in control groups. Due to these factors, the evidence for secondary outcomes is considered to have lower confidence. MST may serve as a promising, optional supportive adjunctive intervention in oncological rehabilitation, but it cannot be recommended as a standalone treatment.

How this fits prior evidence

This meta-analysis addresses a gap in non-pharmacological management for breast cancer-related lymphedema. It complements existing evidence where weight reduction was found effective for limb volume and VR-based training was effective for pain. While this study suggests MST may reduce both limb circumference and pain, the results are tempered by performance bias and control group variations.

Researchers analyzed data from over 900 patients to see if a specific massage technique called Meridian Sinew Tuina (MST) could help manage breast cancer-related lymphedema. This technique involves deep tissue mobilization using methods like plucking, kneading, and pressing along specific body lines. The study found that patients who received MST showed a significant reduction in upper limb circumference compared to those who did not.

In addition to smaller limb sizes, the study reported that patients receiving the massage saw improvements in pain levels and overall quality of life. They also reported better scores on functional tests, which measure how well they could perform daily activities. These improvements were measured at a three-month follow-up point.

While these results are encouraging, the evidence is not yet strong enough to recommend this treatment as a standard standalone therapy. The study had limitations, such as the fact that participants knew which treatment they were receiving. Because of these factors, MST is currently viewed as a helpful extra option for recovery rather than a replacement for standard medical care.

What this means for you:
Meridian Sinew Tuina may help reduce swelling and pain, but it is currently considered a supportive addition to care.

Common questions

What is Meridian Sinew Tuina?

Meridian Sinew Tuina is a deep tissue massage technique. It involves plucking, kneading, and pressing along specific lines on the body. In this study, it was used to help manage swelling and pain for patients with breast cancer-related lymphedema.

Can this massage reduce swelling and pain?

The study found that patients who received the massage had a significant reduction in upper limb circumference. They also reported a reduction in pain intensity and improved scores on functional tests after a three-month period.

Is this a replacement for standard medical treatment?

No, this treatment is not recommended as a standalone replacement for standard care. It is currently viewed as a promising, optional addition to help support recovery for patients dealing with lymphedema.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up3.0 mo
PublishedDec 2026
View Original Abstract ↓
BACKGROUND: Complex Decongestive Therapy (CDT) is the non-operative standard for breast cancer-related lymphedema (BCRL), but many patients experience persistent subcutaneous stiffness, pain, and restricted mobility. This study systematically reviews the safety and clinical efficacy of Meridian Sinew Tuina (MST) protocols for BCRL. METHODS: Global and regional databases (PubMed, Cochrane Library, Embase, Web of Science, CNKI, Wanfang, VIP) were searched from inception to January 15, 2026, with alerts monitored through April 30, 2026. Randomised controlled trials (RCTs) evaluating MST (deep tissue mobilisation along the six-hand meridian sinew [] lines via plucking, kneading, and pressing) were included. Two reviewers independently extracted data, evaluated risk of bias using Cochrane RoB 2, and assessed evidence certainty via GRADE using a random-effects model. RESULTS: Fifteen RCTs were included. For the primary anthropometric outcome, MST significantly reduced upper limb circumference compared to controls (SMD = 1.59; 95% CI: 1.44 to 1.74; Z = 20.81; p < 0.0001; =0.0%; N = 924; GRADE: ). The Clinical Response Efficacy Rate (≥ 30% swelling reduction and symptom relief) favoured MST (RR = 1.69; 95% CI: 1.54 to 1.87; Z = 10.62; p < 0.0001; =0.0%; N = 1,114; GRADE: ). Trial Sequential Analysis confirmed sample size sufficiency. For secondary outcomes (N = 924; GRADE: due to performance bias and clinical heterogeneity), MST showed favourable 3-month improvements in DASH functional scores (SMD = -1.81; 95% CI: -2.11 to -1.51; =45.1%), pain intensity (SMD = -2.44; 95% CI: -2.93 to -1.95; =50.4%), and quality of life (SMD = 1.04; 95% CI: 0.79 to 1.29; =0.0%). No serious adverse events occurred. CONCLUSIONS: MST protocols are associated with favourable short- and mid-term reductions in upper limb swelling. However, confidence is tempered by unblinded performance bias and control group variations. MST cannot be unconditionally recommended for standalone implementation but represents a promising, optional supportive adjunctive intervention within oncological rehabilitation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.